Multiple muscles in the AMD quail can be ?cross-corrected? of pathologic glycogen accumulation after intravenous injection of an [E1-, polymerase-] adenovirus vector encoding human acid-?-glucosidase

This publication has 14 references indexed in Scilit:

• Efficacy of Gene Therapy for a Prototypical Lysosomal Storage Disease (GSD-II) Is Critically Dependent on Vector Dose, Transgene Promoter, and the Tissues Targeted for Vector Transduction
  Molecular Therapy, 2002
• Long-Term Efficacy after [E1^-, polymerase^-] Adenovirus-Mediated Transfer of Human Acid-α-Glucosidase Gene into Glycogen Storage Disease Type II Knockout Mice
  Human Gene Therapy, 2001
• Intercellular Transfer of the Virally Derived Precursor Form of Acid α-Glucosidase Corrects the Enzyme Deficiency in Inherited Cardioskeletal Myopathy Pompe Disease
  Human Gene Therapy, 2001
• Multiply deleted [E1, polymerase-, and pTP-] adenovirus vector persists despite deletion of the preterminal protein
  The Journal of Gene Medicine, 2000
• Recombinant human α-glucosidase from rabbit milk in Pompe patients
  The Lancet, 2000
• Systemic correction of the muscle disorder glycogen storage disease type II after hepatic targeting of a modified adenovirus vector encoding human acid-α-glucosidase
  Proceedings of the National Academy of Sciences, 1999
• Adenovirus-Mediated Transfer of Human Acid Maltase Gene Reduces Glycogen Accumulation in Skeletal Muscle of Japanese Quail with Acid Maltase Deficiency
  Human Gene Therapy, 1998
• Clinical and metabolic correction of pompe disease by enzyme therapy in acid maltase-deficient quail.
  Journal of Clinical Investigation, 1998
• Molecular cloning of acid α-glucosidase cDNA of Japanese quail (Coturnix coturnix japonica) and the lack of its mRNA in acid maltase deficient quails
  Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1997
• High-level production of recombinant human lysosomal acid alpha-glucosidase in Chinese hamster ovary cells which targets to heart muscle and corrects glycogen accumulation in fibroblasts from patients with Pompe disease.
  Proceedings of the National Academy of Sciences, 1996